Entera Bio (ENTX) Exchange Rate Effect (2025 - 2026)

Entera Bio's (ENTX) quarterly Exchange Rate Effect came in at $4000.0 in Q1 2026, up 106.15% on a QoQ basis from -$65000.0 in Q4 2025.

Entera Bio (ENTX) Exchange Rate Effect (2025 - 2026) Analysis & Trends

Entera Bio (ENTX) has 2 years of Exchange Rate Effect data on file, last reported at $4000.0 in Q1 2026.

Quarterly Exchange Rate Effect changed N/A year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61000.0 (changed N/A YoY) and the FY2025 annual result came in at -$36000.0, changed N/A from the prior year.
Exchange Rate Effect climbed to $4000.0 in Q1 2026, from -$65000.0 in the prior quarter.
In the past five years, Exchange Rate Effect ranged from a high of $4000.0 in Q1 2026 to a low of -$65000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-300,000.00
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-2.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	19.84 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-2.45 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.63 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-287,000.00
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Entera Bio	161.44 Mn	150.13 Mn	-	17,000.00

Download Data